Leveraging Effective Clinical Supply Strategies to Meet Complex Challenges in China and APAC ( In Chinese )
Summary: As the number of China National Medical Products Administration (NMPA) clinical trials applications continues to grow every year, having comprehensive and efficient clinical supply strategies to support these studies has become more important. Of critical importance is the ability of clinical sponsors to understand and remain compliant with all relevant regulations, while balancing the need to achieve desired timelines and maintain flexibility through effective clinical supply management practices. In this webinar, Leo Xu, Project Manager at Catalent’s Shanghai facility, addresses the latest trends and challenges awaiting sponsors running studies within China and the broader APAC markets, and discusses possible solutions a sponsor should consider and implement for success in this diverse region.